다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

ALVO

Alvontech (ALVO)

Alvontech

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALVO

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/14	06:05	GlobeNewswire Inc.	Alvotech Reports Financial Results for the First Nine Months of 2024	NASDAQ:ALVO	Alvontech
2024/11/07	22:00	GlobeNewswire Inc.	Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024	NASDAQ:ALVO	Alvontech
2024/11/04	21:00	GlobeNewswire Inc.	European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)	NASDAQ:ALVO	Alvontech
2024/10/30	21:30	GlobeNewswire Inc.	Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET	NASDAQ:ALVO	Alvontech
2024/10/25	21:00	GlobeNewswire Inc.	Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024	NASDAQ:ALVO	Alvontech
2024/10/22	20:00	GlobeNewswire Inc.	Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)	NASDAQ:ALVO	Alvontech
2024/10/10	18:00	GlobeNewswire Inc.	European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®	NASDAQ:ALVO	Alvontech
2024/09/25	18:00	GlobeNewswire Inc.	Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®	NASDAQ:ALVO	Alvontech
2024/08/26	22:14	GlobeNewswire Inc.	Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference	NASDAQ:ALVO	Alvontech
2024/08/16	18:57	IH Market News	H&R Block Shares Surge 10% on Profit and Dividend Boost, Applied Materials Drops 3% Despite Strong Earnings, Latest in Earnings	NASDAQ:ALVO	Alvontech
2024/08/16	05:15	GlobeNewswire Inc.	Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024	NASDAQ:ALVO	Alvontech
2024/08/15	19:09	IH Market News	U.S. Futures Rise on Easing Inflation, Oil Prices Rise	NASDAQ:ALVO	Alvontech
2024/08/15	17:30	GlobeNewswire Inc.	European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)	NASDAQ:ALVO	Alvontech
2024/08/02	05:02	GlobeNewswire Inc.	Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET	NASDAQ:ALVO	Alvontech
2024/07/22	19:30	GlobeNewswire Inc.	STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe	NASDAQ:ALVO	Alvontech
2024/07/11	17:45	GlobeNewswire Inc.	Alvotech Announces Closing of Private Debt Financing	NASDAQ:ALVO	Alvontech
2024/07/02	22:00	GlobeNewswire Inc.	Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®	NASDAQ:ALVO	Alvontech
2024/07/02	06:35	GlobeNewswire Inc.	Alvotech Issues New Shares to Holders of Convertible Bonds	NASDAQ:ALVO	Alvontech
2024/07/01	18:10	GlobeNewswire Inc.	Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the Second Quarter of 2024	NASDAQ:ALVO	Alvontech
2024/06/26	17:50	GlobeNewswire Inc.	Alvotech Receives Conversion Notices for Majority of Convertible Bonds	NASDAQ:ALVO	Alvontech
2024/06/18	17:01	GlobeNewswire Inc.	Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe	NASDAQ:ALVO	Alvontech
2024/06/11	17:00	GlobeNewswire Inc.	Alvotech and STADA add to strategic alliance through denosumab partnership	NASDAQ:ALVO	Alvontech
2024/06/07	17:00	GlobeNewswire Inc.	Alvotech Announces Strategic Refinancing Agreement	NASDAQ:ALVO	Alvontech
2024/05/29	21:05	GlobeNewswire Inc.	Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024	NASDAQ:ALVO	Alvontech
2024/05/22	06:15	GlobeNewswire Inc.	Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update	NASDAQ:ALVO	Alvontech
2024/05/21	23:05	Business Wire	Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK	NASDAQ:ALVO	Alvontech
2024/05/21	21:00	GlobeNewswire Inc.	Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK	NASDAQ:ALVO	Alvontech
2024/05/21	20:13	IH Market News	U.S. Index Futures Open Lower Amid Nasdaq Record, Fed Speeches	NASDAQ:ALVO	Alvontech
2024/05/21	09:25	Business Wire	Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	NASDAQ:ALVO	Alvontech
2024/05/21	09:25	GlobeNewswire Inc.	Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	NASDAQ:ALVO	Alvontech

검색 관련기사 보기:NASDAQ:ALVO

1 2 3 4 5 다음 >>

Gold vs US Dollar

Financial Select Sector

BNP Paribas (QX)

Bank of America

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관